Glucose Health, Inc. confirmed that CVS HEALTH CORP has agreed to distribute the Company's innovative beverage for the adult-diabetic nutrition retail category, GLUCODOWN®. Many clinical studies underpin the efficacy of the principal nutritional ingredient in GLUCODOWN®. Clinical data generated from this research was submitted to the Food & Drug Administration (FDA) by the ingredient manufacturer, resulting last year in favorable revision to FDA regulations and industry guidance with regard to the labeling of products utilizing the ingredient, including GLUCODOWN®.